XBiotech Inc. is a biopharmaceutical company that focuses on the development and commercialization of targeted antibody therapies. With a pipeline of innovative drug candidates addressing unmet medical needs, XBiotech is paving the way for new and improved treatments in oncology, dermatology, and infectious diseases. With a commitment to patient-centric research, the company is poised to make a significant impact in the healthcare industry.
